SHP2-mediated mitophagy boosted by lovastatin in neuronal cells alleviates parkinsonism in mice
Main Authors: | Wen Liu, Meijing Wang, Lihong Shen, Yuyu Zhu, Hongyue Ma, Bo Liu, Liang Ouyang, Wenjie Guo, Qiang Xu, Yang Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-01-01
|
Series: | Signal Transduction and Targeted Therapy |
Online Access: | https://doi.org/10.1038/s41392-021-00474-x |
Similar Items
-
SHP2 allosteric inhibitor TK-453 alleviates psoriasis-like skin inflammation in mice via inhibition of IL-23/Th17 axis
by: Meijing Wang, et al.
Published: (2022-04-01) -
Allosteric inhibition of SHP2 uncovers aberrant TLR7 trafficking in aggravating psoriasis
by: Yuyu Zhu, et al.
Published: (2022-03-01) -
Tyrosine phosphatase SHP2 exacerbates psoriasis‐like skin inflammation in mice via ERK5‐dependent NETosis
by: Yan Ding, et al.
Published: (2022-03-01) -
Lovastatin protects against experimental plague in mice.
by: Saravanan Ayyadurai, et al.
Published: (2010-01-01) -
Celastrol Inhibits Dopaminergic Neuronal Death of Parkinson’s Disease through Activating Mitophagy
by: Ming-Wei Lin, et al.
Published: (2019-12-01)